Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

Frédéric E Lecouvet, Daniela E Oprea-Lager, Yan Liu, Piet Ost, Luc Bidaut, Laurence Collette, Christophe M Deroose, Karolien Goffin, Ken Herrmann, Otto S Hoekstra, Gem Kramer, Yolande Lievens, Egesta Lopci, David Pasquier, Lars J Petersen, Jean-Noël Talbot, Helle Zacho, Bertrand Tombal, Nandita M deSouza

Research output: Contribution to journalReview articleResearchpeer-review

39 Citations (Scopus)
74 Downloads (Pure)
Original languageEnglish
JournalThe Lancet. Oncology
Volume19
Issue number10
Pages (from-to)e534-e545
Number of pages12
ISSN1470-2045
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group'. Together they form a unique fingerprint.

  • Cite this

    Lecouvet, F. E., Oprea-Lager, D. E., Liu, Y., Ost, P., Bidaut, L., Collette, L., Deroose, C. M., Goffin, K., Herrmann, K., Hoekstra, O. S., Kramer, G., Lievens, Y., Lopci, E., Pasquier, D., Petersen, L. J., Talbot, J-N., Zacho, H., Tombal, B., & deSouza, N. M. (2018). Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group. The Lancet. Oncology, 19(10), e534-e545. https://doi.org/10.1016/S1470-2045(18)30571-0